Page last updated: 2024-08-24

3-iodobenzylguanidine and (4-fluoro-3-iodobenzyl)guanidine

3-iodobenzylguanidine has been researched along with (4-fluoro-3-iodobenzyl)guanidine in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's4 (80.00)18.2507
2000's1 (20.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Affleck, DJ; Vaidyanathan, G; Zalutsky, MR2
Strickland, DK; Vaidyanathan, G; Zalutsky, MR; Zhao, XG1
Larsen, RH; Vaidyanathan, G; Zalutsky, MR; Zhao, XG1
Affleck, DJ; Alston, KL; Vaidyanathan, G; Welsh, P; Zalutsky, MR1

Other Studies

5 other study(ies) available for 3-iodobenzylguanidine and (4-fluoro-3-iodobenzyl)guanidine

ArticleYear
Validation of 4-[fluorine-18]fluoro-3-iodobenzylguanidine as a positron-emitting analog of MIBG.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1995, Volume: 36, Issue:4

    Topics: 3-Iodobenzylguanidine; Animals; Contrast Media; Fluorine Radioisotopes; Humans; In Vitro Techniques; Iodine Radioisotopes; Iodobenzenes; Mice; Mice, Inbred BALB C; Radiation Dosage; Tissue Distribution; Tomography, Emission-Computed; Tumor Cells, Cultured

1995
(4-[18F]fluoro-3-iodobenzyl)guanidine, a potential MIBG analogue for positron emission tomography.
    Journal of medicinal chemistry, 1994, Oct-14, Volume: 37, Issue:21

    Topics: 3-Iodobenzylguanidine; Adrenal Glands; Animals; Contrast Media; Fluorine Radioisotopes; Humans; Iodobenzenes; Lipid Metabolism; Mice; Mice, Inbred BALB C; Myocardium; Neuroblastoma; Tissue Distribution; Tomography, Emission-Computed; Tumor Cells, Cultured

1994
No-carrier-added iodine-131-FIBG: evaluation of an MIBG analog.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1997, Volume: 38, Issue:2

    Topics: 3-Iodobenzylguanidine; Animals; Fluorine Radioisotopes; Humans; Iodine Radioisotopes; Iodobenzenes; Mice; Mice, Inbred BALB C; Neuroblastoma; Radiopharmaceuticals; Tissue Distribution; Tomography, Emission-Computed; Tumor Cells, Cultured

1997
3-[211At]astato-4-fluorobenzylguanidine: a potential therapeutic agent with prolonged retention by neuroblastoma cells.
    British journal of cancer, 1997, Volume: 76, Issue:2

    Topics: 3-Iodobenzylguanidine; Animals; Antineoplastic Agents; Astatine; Binding Sites; Guanidines; Humans; Iodine Radioisotopes; Iodobenzenes; Male; Mice; Mice, Inbred BALB C; Neuroblastoma; Tissue Distribution; Tumor Cells, Cultured

1997
Catabolism of 4-fluoro-3-iodobenzylguanidine and meta-iodobenzylguanidine by SK-N-SH neuroblastoma cells.
    Nuclear medicine communications, 2004, Volume: 25, Issue:9

    Topics: 3-Iodobenzylguanidine; Cell Line, Tumor; Humans; Iodobenzenes; Metabolic Clearance Rate; Neuroblastoma; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity

2004